Portfolio company
Reapplix
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
1 investor
Sectors
About
This company develops blood-derived patches used by healthcare providers to treat patients with hard-to-heal diabetic foot ulcers.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
Plasmacure
This company develops cold plasma medical devices for healthcare professionals to treat chronic wounds such as diabetic foot ulcers and pressure sores.
Transdermal Diagnostics
This company develops needle-free, continuous glucose monitoring patches for people living with diabetes and prediabetes to manage blood sugar levels non-invasively.
DEBx Medical
This company develops chemical debridement agents for healthcare professionals to treat chronic wounds by removing infection and biofilm.
Piomic Medical
This company develops a portable medical device using concurrent optical and magnetic stimulation to treat chronic leg and foot ulcers for healthcare providers.
Advanced BioHealing
The company produces bioengineered tissue and cell-based treatments for healthcare providers to treat diabetic foot ulcers and chronic wounds.
Calibra Medical
This company develops wearable, mechanical insulin delivery patches for individuals with type one and type two diabetes to simplify mealtime therapy.
Omeza
This company develops marine-derived wound care products using fish peptides for healthcare providers treating patients with chronic or hard-to-heal skin ulcers.
Podium Care
The company manufactures thermal imaging monitors and monitoring software to help clinicians and diabetic patients identify early signs of foot ulcers.
